Laboratory diagnostics market in East Africa: A survey of test types, test availability, and test prices in Kampala, Uganda

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Schroeder, Lee F ^a   Elbireer, Ali ^b,c   Jackson, J Brooks ^d   Amukele, Timothy K ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN;

AFRICA; ARTICLE; BLOOD GROUP TYPING; BRUCELLOSIS; DIAGNOSTIC TEST; FECES ANALYSIS; GLUCOSE TOLERANCE TEST; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HIV TEST; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MALARIA; POINT OF CARE TESTING; POPULATION RESEARCH; QUESTIONNAIRE; SEROLOGY; TYPHOID FEVER; UGANDA; URINALYSIS; COMMERCIAL PHENOMENA; CROSS-SECTIONAL STUDY; ECONOMICS; POINT OF CARE SYSTEM; STATISTICS AND NUMERICAL DATA;

CLINICAL LABORATORY TECHNIQUES; COMMERCE; CROSS-SECTIONAL STUDIES; HEALTH CARE COSTS; HUMANS; POINT-OF-CARE SYSTEMS; UGANDA;

EID: 84942337306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134578     Document Type: Article

References (32)

1. Ferrante di Ruffano L, Hyde CJ, McCaffery KJ, Bossuyt PMM, Deeks JJ. Assessing the value of diagnostic tests: a framework for designing and evaluating trials. BMJ. 2012; 344: e686. doi: 10.1136/bmj.e686 PMID: 22354600
2. Urdea M, Penny LA, Olmsted SS, Giovanni MY, Kaspar P, Shepherd A, et al. Requirements for high impact diagnostics in the developing world. Nature. 2006; 444 Suppl: 73-9.
3. Burgess D, Wasserman J, Dahl CA. Global Health Diagnostics. Nature. 2006; 444: 1-2.
4. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis. 2006; 42: 377-82. PMID: 16392084
5. Palamountain KM, Baker J, Cowan EP, Essajee S, Mazzola LT, Metzler M, et al. Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis. 2012; 205 Suppl: S181-90.
6. Malaria Diagnostics Technology Landscape. 2nd edition. Unitaid Secretariat, World Health Organization. 2014.
7. HIV/AIDS Diagnostics Technology Landscape. 4th edition. Unitaid Secretariat, World Health Organization. 2014.
8. UNITAID. Tuberculosis Diagnostics Technology and Market Landscape 3. 2014.
9. Global Burden of Disease Study 2010 (GBD 2010) Results by Risk Factor 1990-2010. Seattle, United States: Institute for Health Metrics and Evaluation (IHME). 2012.
10. Barbiero VK. Fulfilling the PEPFAR mandate: a more equitable use of PEPFAR resources across global health. 2010; 289-293.
11. United Nations. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Sixty-sixth session Agenda item 117. 2012.
12. United States Agency for International Development (USAID). The DHS Program, Demographic and Health Surveys [Internet]. Available: http://www.dhsprogram.com/.
13. International Bank for Reconstruction and Development / The World Bank. Healthy Partnerships: How Governments Can Engage the Private Sector to Improve Health in Africa. 2011.
14. Amukele TK, Schroeder LF, Jackson JB, Elbireer A. Most clinical laboratory testing in kampala occurs in high-volume, high-quality laboratories or low-volume, low-quality laboratories: a tale of two cities. Am J Clin Pathol. 2015; 143: 50-6. doi: 10.1309/AJCPCYA54DWZQPQT PMID: 25511142
15. Elbireer AM, Jackson JB, Sendagire H, Opio A, Bagenda D, Amukele TK. The good, the bad, and the unknown: quality of clinical laboratories in kampala, Uganda. PLoS One. 2013; 8: e64661. doi: 10.1371/journal.pone.0064661 PMID: 23737993
16. World Health Organization Regional Office for Africa. 2012. WHO Guide for the Stepwise Laboratory Improvement Process Towards Accreditation in the African Region (with checklist). Available: http://www.afro.who.int/en/clusters-a-programmes/hss/blood-safety-laboratories-a-health-technology/blt-highlights/3859-who-guide-for-the-stepwise-laboratory-improvement-process-towards-accreditation-in-the-african-region-with-checklist.html. Accessed 2014 September 23.
17. The World Bank. World Development Indicators [Internet].
18. Center for Medicare and Medicaid Services, Clinical Laboratory Fee Schedule [Internet]. 2013. Available: http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/clinlab.html. Accessed 2014 Aug 9.
19. Uganda Bureau of Statistics (UBOS), Statistics House, Kampala U. Statistical Abstract. 2012.
20. Lewin Group. Laboratory Medicine: A National Status Report Laboratory Medicine: A National Status Report. 2008.
21. Provider of Services File. The Centers for Medicare and Medicaid Services (CMS). Center for Medicare and Medicaid Services (CMS); 2012.
22. Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, et al. Defining the Needs for Next Generation Assays for Tuberculosis. J Infect Dis. 2015; 211: S29-S38. doi: 10.1093/infdis/jiu821 PMID: 25765104
23. Nabukenya I, Kaddu-Mulindwa D, Nasinyama GW. Survey of Brucella infection and malaria among Abattoir workers in Kampala and Mbarara Districts, Uganda. BMC Public Health. BMC Public Health; 2013; 13: 901. doi: 10.1186/1471-2458-13-901 PMID: 24079448
24. Steingart KR, Ramsay A, Dowdy DW, Pai M. Serological tests for the diagnosis of active tuberculosis: Relevance for India. Indian J Med Res. 2012; 135: 695-702. PMID: 22771604
25. Jarosławski S, Pai M. Why are inaccurate tuberculosis serological tests widely used in the Indian private healthcare sector? A root-cause analysis. J Epidemiol Glob Health. 2012; 2: 39-50. doi: 10.1016/j.jegh.2011.12.001 PMID: 23856397
26. Steingart KR, Flores LL, Dendukuri N, Schiller I, Laal S, Ramsay A, et al. Commercial Serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: An updated systematic review and Meta-Analysis. PLoS Med. 2011; 8.
27. Dowdy DW, Steingart KR, Pai M. Serological testing versus other strategies for diagnosis of active tuberculosis in india: A cost-effectiveness analysis. PLoS Med. 2011; 8.
28. World Health Organization. Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement. Geneva; 2011.
29. Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nat Rev Microbiol. 2004; 2: 231-40. PMID: 15083158
30. Schroeder LF, Amukele T. Medical laboratories in sub-saharan Africa that meet international quality standards. Am J Clin Pathol. 2014; 141: 791-5. doi: 10.1309/AJCPQ5KTKAGSSCFN PMID: 24838322
31. Stull TM, Hearn TL, Hancock JS, Handsfield JH, Collins CL. Variation in proficiency testing performance by testing site. JAMA. 1998; 279: 463-467. PMID: 9466641
32. Levinson DR. Comparing Lab Test Payment Rates: Medicare Could Achieve Substantial Savings. Department of Health and Human Services, Office of the Inspector General. 2013.